Meticillin-resistant Staphylococcus aureus (MRSA) is well established as a major pathogen in healthcare-associated infections, but in recent years it has also become increasingly common in community-acquired infections. Community-acquired MRSA (CA-MRSA) strains are characterized by the predominance of staphylococcal chromosomal cassette mec (SCCmec) type IV, the lack of multi-drug resistance, and the presence of specific toxins, including Panton-Valentine leukocidin (PVL) and occasionally exfoliative toxins. CA-MRSA has been shown to arise from diverse clones rather than from the worldwide spread of specific clones, and in Asian countries the most predominant PVL-positive CA-MRSA clone is sequence type (ST)30 (Takizawa et al., 2005; Hsu et al., 2006; Wijaya et al., 2006) .
In Korea, healthcare-associated MRSA (HA-MRSA) has risen dramatically over the last decade and currently accounts for up to 70 % of S. aureus infections in most tertiary care hospitals (Kim et al., 2003; Cha et al., 2005) SSSS was the most common disease presentation, accounting for 9 of the 23 (37.5 %) cases, followed by skin and soft tissue infections (impetigo and abscesses) in a further 9 patients (Table 1) . ST89 was restricted to SSSS isolates, whereas ST72 was associated with a wide range of clinical manifestations in children and adults. 
